Clinical Trials Logo

Filter by:
NCT ID: NCT01338142 Not yet recruiting - Postmenopause Clinical Trials

Amorphous Calcium Carbonate (Acc) Versus Crystalline Calcium Carbonate (Ccc) Using Stable Calcium Isotopes In Postmenopausal Women

Start date: May 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The study objective is, to evaluate the fractional absorption of calcium from amorphous calcium carbonate (ACC) Vs crystalline calcium carbonate (CCC) dietary supplements in postmenopausal women.

NCT ID: NCT01338129 Not yet recruiting - Ankle Fracture Clinical Trials

The Effect of Vitamin c on Preventing Complex Regional Pain Syndrome (CRPS Type I) Following Ankle Fracture

CRPS
Start date: April 2011
Phase: N/A
Study type: Interventional

The use of prophylactic treatment with vitamin c may prevent complex regional pain syndrome (CRPS)

NCT ID: NCT01338064 Not yet recruiting - Silicosis Clinical Trials

Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)

Start date: September 2011
Phase: N/A
Study type: Observational

Silicosis is well-known occupational disease caused by free crystalline silica (silicon dioxide) and is marked by inflammation and pulmonary fibrosis. There are cumulative evidences that exposure to Caesar stone (quartz surface products that manufactured from up to 93% quartz, polymer resins and pigments) is particularly dangerous to exposed workers. Goals: To examine marble workers exposed to Caesar Stone in order to propose a working plan of surveillance and prevention by biological monitoring.

NCT ID: NCT01331603 Not yet recruiting - Clinical trials for Myelodysplastic Syndrome

Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis

Start date: March 2011
Phase: N/A
Study type: Observational

Recently, it has been demonstrated that iron overload is associated with the appearance of labile plasma iron (LPI). LPI is redox active and is rapidly taken up by cells, leading to a rise in the labile iron pool (LIP) and catalyzing generation of reactive oxygen species (ROS), which can lead to cellular damage. The LPI data are mostly derived from thalassemia iron overload research , however, there are a few data describing LPI and its correlations with the classical iron overload parameters (ferritin, TSAT) in acute anemias such as MDS Therefore we are going to assess LPI in iron overloaded myelodysplastic syndromes (MDS) (low and high risk) and primary myelofibrosis, in order to assess whether it can be used as alternative to the routinely used parameters; TSAT and ferritin levels.

NCT ID: NCT01330732 Not yet recruiting - Kyphosis Clinical Trials

Kyphosis Evaluation Using SPINESCAN®

Start date: December 2008
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the accuracy of SPINESCAN® with standard lateral x-rays of the spine in patients monitored for kyphosis.

NCT ID: NCT01329471 Not yet recruiting - Clinical trials for Acute Myeloid Leukemia

Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)

Start date: April 2011
Phase: N/A
Study type: Observational

The purpose of this study is to elucidate the role of RUNX1 in Acute Myeloid Leukemia (AML), in particular, the transcriptional regulation of genes by mutated forms of this protein. This research will study the effect of mutations found in AML patients

NCT ID: NCT01329003 Not yet recruiting - Silicosis Clinical Trials

DNA-damage Pathways in Workers Exposed to Silica (Caesar Stone)

Start date: September 2011
Phase: N/A
Study type: Observational

Silicosis is well-known occupational disease caused by free crystalline silica (silicon dioxide) and is marked by inflammation and pulmonary fibrosis. There are cumulative evidences that exposure to Caesar stone (quartz surface products that manufactured from up to 93% quartz, polymer resins and pigments) is particularly dangerous to exposed workers. Goals: To examine correlation between disease and exposure to Caesar stone and genetic differences regarding genes involved in oxidative stress to understand Genetic susceptibility

NCT ID: NCT01326403 Not yet recruiting - Clinical trials for Closed Fracture of Hip

Tranexamic Acid in Hip Fracture Patients

Start date: June 2012
Phase: N/A
Study type: Interventional

This is a randomized controlled trial comparing the use of tranexamic acid to placebo in patients admitted to hospital with a hip fracture.

NCT ID: NCT01322477 Not yet recruiting - Clinical trials for Hepatocellular Carcinoma

Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency

HCC
Start date: n/a
Phase: N/A
Study type: Observational

HCC (Hepato-cellular Carcinoma) is the fifth most frequent cancer in humans and its prevalence is growing. The most effective treatment of HCC is surgical and includes resection and liver transplantation; however, only 20% of the patients can be treated surgically. Local interventional therapy, such as radiofrequency (RF) ablation and transarterial embolization is also used. Recurrence rate is very high, and extrahepatic disease develops in about 30% of the cases and in up to 20% after liver transplantation. Systemic treatment is thus an option. Sorafenib (multi-kinase inhibitor) is the first agent to significantly improve the overall survival in advanced HCC. However, the drug has serious side effects and is very expensive. PET/CT with F18-FDG is a common tool for systemic evaluation and staging of various tumors. The value of the FDG PET for evaluation of HCC is controversial, in particular due to the unique metabolic pathway of glucose in the HCC cells. Since 2007 more and more studies suggest the feasibility of FDG PET/CT for monitoring local recurrence (especially after RF) and metastatic spread of HCC, including detection of active disease only suspected by AFP (alphafoetoprotein) elevation. Early detection of treatment response to therapy by whole body FDG PET/CT allows for change of treatment as early as possible,when the tumor is non-responsive before serious side effects appear or before depletion of body resources. The aim of our study is to investigate the contribution of FDG PET/CT to assessment of treatment response.

NCT ID: NCT01322126 Not yet recruiting - Regional Anesthesia Clinical Trials

Comparison of Safety And Efficacy of Neuraxial Anesthesia, Palpation Versus Ultrasound

Start date: April 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether use of the ultrasound to locate the epidural space and assist with performing neuraxial anesthesia will decrease numbers of the attempts required for successful placement of epidural catheter.